248 related articles for article (PubMed ID: 18789702)
1. Anacardic acid derivatives as inhibitors of glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi.
Pereira JM; Severino RP; Vieira PC; Fernandes JB; da Silva MF; Zottis A; Andricopulo AD; Oliva G; Corrêa AG
Bioorg Med Chem; 2008 Oct; 16(19):8889-95. PubMed ID: 18789702
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
Freitas RF; Prokopczyk IM; Zottis A; Oliva G; Andricopulo AD; Trevisan MT; Vilegas W; Silva MG; Montanari CA
Bioorg Med Chem; 2009 Mar; 17(6):2476-82. PubMed ID: 19254846
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure.
Castilho MS; Pavão F; Oliva G; Ladame S; Willson M; Périé J
Biochemistry; 2003 Jun; 42(23):7143-51. PubMed ID: 12795610
[TBL] [Abstract][Full Text] [Related]
4. The development of an immobilized enzyme reactor containing glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi: the effect of species' specific differences on the immobilization.
Cardoso CL; de Moraes MC; Guido RV; Oliva G; Andricopulo AD; Wainer IW; Cass QB
Analyst; 2008 Jan; 133(1):93-9. PubMed ID: 18087619
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of Trypanosoma cruzi GAPDH by "bi-substrate" analogues.
Ladame S; Fauré R; Denier C; Lakhdar-Ghazal F; Willson M
Org Biomol Chem; 2005 Jun; 3(11):2070-2. PubMed ID: 15917890
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies.
Guido RV; Oliva G; Montanari CA; Andricopulo AD
J Chem Inf Model; 2008 Apr; 48(4):918-29. PubMed ID: 18303835
[TBL] [Abstract][Full Text] [Related]
7. Effects of organic solvents on the enzyme activity of Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase in calorimetric assays.
Wiggers HJ; Cheleski J; Zottis A; Oliva G; Andricopulo AD; Montanari CA
Anal Biochem; 2007 Nov; 370(1):107-14. PubMed ID: 17693383
[TBL] [Abstract][Full Text] [Related]
8. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
Aronov AM; Verlinde CL; Hol WG; Gelb MH
J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
[TBL] [Abstract][Full Text] [Related]
9. New 3-piperonylcoumarins as inhibitors of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) from Trypanosoma cruzi.
de Marchi AA; Castilho MS; Nascimento PG; Archanjo FC; del Ponte G; Oliva G; Pupo MT
Bioorg Med Chem; 2004 Sep; 12(18):4823-33. PubMed ID: 15336261
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
Schormann N; Velu SE; Murugesan S; Senkovich O; Walker K; Chenna BC; Shinkre B; Desai A; Chattopadhyay D
Bioorg Med Chem; 2010 Jun; 18(11):4056-66. PubMed ID: 20452776
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification and kinetic characterization of His-tagged glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi.
Cheleski J; Freitas RF; Wiggers HJ; Rocha JR; de Araújo AP; Montanari CA
Protein Expr Purif; 2011 Apr; 76(2):190-6. PubMed ID: 21138769
[TBL] [Abstract][Full Text] [Related]
13. Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.
Suresh S; Bressi JC; Kennedy KJ; Verlinde CL; Gelb MH; Hol WG
J Mol Biol; 2001 Jun; 309(2):423-35. PubMed ID: 11371162
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Trypanosoma cruzi dihydroorotate dehydrogenase from Y strain.
Pinheiro MP; Iulek J; Cristina Nonato M
Biochem Biophys Res Commun; 2008 May; 369(3):812-7. PubMed ID: 18302934
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of an immobilized enzyme reactor (IMER) based on human glyceraldehyde-3-phosphate dehydrogenase for on-line enzymatic studies.
Cardoso CL; Lima VV; Zottis A; Oliva G; Andricopulo AD; Wainer IW; Moaddel R; Cass QB
J Chromatogr A; 2006 Jul; 1120(1-2):151-7. PubMed ID: 16297925
[TBL] [Abstract][Full Text] [Related]
16. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
17. Lipoxygenase inhibitory activity of anacardic acids.
Ha TJ; Kubo I
J Agric Food Chem; 2005 Jun; 53(11):4350-4. PubMed ID: 15913294
[TBL] [Abstract][Full Text] [Related]
18. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors.
Maluf FV; Andricopulo AD; Oliva G; Guido RV
Future Med Chem; 2013 Nov; 5(17):2019-35. PubMed ID: 24215344
[TBL] [Abstract][Full Text] [Related]
19. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
20. 16-bromoepiandrosterone, an activator of the mammalian immune system, inhibits glucose 6-phosphate dehydrogenase from Trypanosoma cruzi and is toxic to these parasites grown in culture.
Cordeiro AT; Thiemann OH
Bioorg Med Chem; 2010 Jul; 18(13):4762-8. PubMed ID: 20570159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
